Homocysteine and cognitive function in elderly people.
Dementia is highly prevalent among elderly people, and projections show that the number of people affected might triple over the next 50 years, mainly because of a large increase in the oldest-old segment of the population. Because of this and the disease's devastating effects, measures for the prevention and early detection of dementia are crucial. Age and years of education are among the most relevant risk factors for dementia, but in recent years the role of homocysteine has also been investigated. Homocysteine is an amino acid produced in the metabolism of methionine, a process dependent on the B vitamins cobalamin, vitamin B6 and folic acid. There is evidence that increased serum homocysteine levels are associated with declining cognitive function and dementia. We review this evidence in addition to the potential mechanisms through which homocysteine acts on the brain to cause cognitive dysfunction, the metabolism of homocysteine and factors associated with alteration of the normal metabolism.
Department of Medicine, Queen's University, Kingston, Ont. garciaa@pccchealth.org
Angeles
A
Garcia
Katherine
K
Zanibbi
D000368:Aged; D000369:Aged, 80 and over; D003072:Cognition Disorders / Q000097:blood* / Q000453:epidemiology; D003704:Dementia / Q000097:blood* / Q000453:epidemiology; D020022:Genetic Predisposition to Disease; D006710:Homocysteine / Q000097:blood* / Q000187:drug effects / Q000235:genetics; D006801:Humans; D008875:Middle Aged; D012307:Risk Factors; D014803:Vitamin B Complex / Q000494:pharmacology
D006710:Homocysteine; D014803:Vitamin B Complex